Acelity L.P. Inc. And Smith and Nephew Are Dominating the Market for Global Advanced Wound Care Market
Global Advanced Wound Care Market is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024.
(EMAILWIRE.COM, September 27, 2018 ) Global Advanced Wound Care Market is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-advanced-wound-care-market-7
Acelity L.P. INC. is dominated the advanced wound care market in 2016 followed by Smith and Nephew, and Molnlycke Healthcare AB. Other players in this market include 3M, Medtronic, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, MiMedx Group, Organogenesis Inc, Talley Group Limited, BSN Medical, Devon Medical Products.com, Human Biosciences Inc, B.BraunMelsungen AG, Cardinal Health, Paul Hartmann Ltd, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, KCL Licensing Inc., Advancis Medical among others holds 26.0% of the global advanced wound care market in 2016.
ACELITY L.P. INC.:
Acelity L.P. Inc was founded in 1976 and headquartered in San Antonio, Texas. This company designs products to address needs in the areas of advanced wound therapy and regenerative medicine with best-in-class solutions that deliver superior clinical outcomes for patients. The company’s operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Acelity L.P. Inc., operates through two business segments: Advanced Wound Therapy (AWT) and Regenerative Medicine (RM).
Recent Developments:
• In February 2017, Acelity L.P. Inc., announced that it has completed the sale of its regenerative medicine business unit, Life Cell Ccorporation to Allergan for USD 2.9 billion in cash.
• In October 2016, Acelity L.P. Inc. announced the launch of Alloderm Select Duo regenerative tissue matrix in the United States. Alloderm Regenerative Tissue Matrix is the leading biological tissue matrix for soft tissue reinforcement.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-advanced-wound-care-market-7
SMITH AND NEPHEW:
Smith and Nephew was founded in 1856, and headquartered in London, U.K. The Company supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to their diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. The company’s operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Smith and Nephew operate through four business segments: orthopedics reconstruction, advanced wound management, sports medicine, and trauma & extremities.
Recent Developments:
In December 2016, Smith and Nephew was awarded the 2016 French Galien Award for PICO; the novel single-use negative pressure wound therapy (NPWT) system.
MOLNLYCKE HEALTHCARE:
Molnlycke was founded in 1849, and is headquartered in Gothenburg, Sweden. Mölnlycke Health Care is one of the leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. The company design and supplies products and solutions for use in wound treatment, pressure ulcer, infection prevention and surgery. The company’s operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world.
Recent Developments:
• In February 2016, Molnlycke announced the acquisition of Sundance Solutions, a leader in developing innovative solutions for the safe positioning and turning of patients to help prevent pressure ulcers.
Access Full Report: https://databridgemarketresearch.com/reports/global-advanced-wound-care-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Get free sample @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-advanced-wound-care-market-7
Acelity L.P. INC. is dominated the advanced wound care market in 2016 followed by Smith and Nephew, and Molnlycke Healthcare AB. Other players in this market include 3M, Medtronic, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, MiMedx Group, Organogenesis Inc, Talley Group Limited, BSN Medical, Devon Medical Products.com, Human Biosciences Inc, B.BraunMelsungen AG, Cardinal Health, Paul Hartmann Ltd, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, KCL Licensing Inc., Advancis Medical among others holds 26.0% of the global advanced wound care market in 2016.
ACELITY L.P. INC.:
Acelity L.P. Inc was founded in 1976 and headquartered in San Antonio, Texas. This company designs products to address needs in the areas of advanced wound therapy and regenerative medicine with best-in-class solutions that deliver superior clinical outcomes for patients. The company’s operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Acelity L.P. Inc., operates through two business segments: Advanced Wound Therapy (AWT) and Regenerative Medicine (RM).
Recent Developments:
• In February 2017, Acelity L.P. Inc., announced that it has completed the sale of its regenerative medicine business unit, Life Cell Ccorporation to Allergan for USD 2.9 billion in cash.
• In October 2016, Acelity L.P. Inc. announced the launch of Alloderm Select Duo regenerative tissue matrix in the United States. Alloderm Regenerative Tissue Matrix is the leading biological tissue matrix for soft tissue reinforcement.
Inquire before buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-advanced-wound-care-market-7
SMITH AND NEPHEW:
Smith and Nephew was founded in 1856, and headquartered in London, U.K. The Company supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to their diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. The company’s operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Smith and Nephew operate through four business segments: orthopedics reconstruction, advanced wound management, sports medicine, and trauma & extremities.
Recent Developments:
In December 2016, Smith and Nephew was awarded the 2016 French Galien Award for PICO; the novel single-use negative pressure wound therapy (NPWT) system.
MOLNLYCKE HEALTHCARE:
Molnlycke was founded in 1849, and is headquartered in Gothenburg, Sweden. Mölnlycke Health Care is one of the leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. The company design and supplies products and solutions for use in wound treatment, pressure ulcer, infection prevention and surgery. The company’s operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world.
Recent Developments:
• In February 2016, Molnlycke announced the acquisition of Sundance Solutions, a leader in developing innovative solutions for the safe positioning and turning of patients to help prevent pressure ulcers.
Access Full Report: https://databridgemarketresearch.com/reports/global-advanced-wound-care-market/
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
Contact Information:
Data Bridge Market Research
Data Bridge Market Research
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Data Bridge Market Research
Data Bridge Market Research
Tel: +1-888-387-2818
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results